China National Medicines Corporation Ltd.
600511
Rang in Aktien
#4956
China National Medicines Corporation Ltd., in conjunction with its various... China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Aktienkurs
$3.90
Marktkapitalisierung
$2.94B
Veränderung (1 Tag)
-1.46%
Veränderung (1 Jahr)
-3.02%
Land
CN
Handel China National Medicines Corporation Ltd. (600511)
Kategorie
Healthcare
P/B-Verhältnis für China National Medicines Corporation Ltd. (600511)
P/B-Verhältnis zum October 2026 TTM: 1.09
Laut den neuesten Finanzberichten und dem Aktienkurs von China National Medicines Corporation Ltd. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 1.09. Am Ende des Jahres 2023 lag das P/B-Verhältnis bei 1.39.
P/B-Verlauf für China National Medicines Corporation Ltd. von 2000 bis 2026
P/B-Verhältnis zum Jahresende
| Jahr | P/B-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 1.09 | -27.82% |
| 2024 | 1.51 | 8.76% |
| 2023 | 1.39 | -6.41% |
| 2022 | 1.48 | -20.45% |
| 2021 | 1.86 | -42.74% |
| 2020 | 3.25 | 64.75% |
| 2019 | 1.97 | 6.56% |
| 2018 | 1.85 | -26.85% |
| 2017 | 2.53 | -57.27% |
| 2016 | 5.93 | -1.18% |
| 2015 | 6.00 | 0.14% |
| 2014 | 5.99 | 39.72% |
| 2013 | 4.29 | 10.23% |
| 2012 | 3.89 | 0.73% |
| 2011 | 3.86 | -57.60% |
| 2010 | 9.10 | -22.52% |
| 2009 | 11.75 | 42.73% |
| 2008 | 8.23 | -30.44% |
| 2007 | 11.83 | 185.53% |
| 2006 | 4.14 | 221.37% |
| 2005 | 1.29 | -8.00% |
| 2004 | 1.40 | -27.55% |
| 2003 | 1.93 | -31.22% |
| 2002 | 2.81 | -68.47% |
| 2001 | 8.92 | -7.43% |
| 2000 | 9.64 | 0.00% |
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/B-Verhältnis | P/B-Verhältnis-Differenz | Land |
|---|---|---|---|
| -27.3394 | -2,608.43% |
US
|
|
| - | - |
US
|
|
| -20.2798 | -1,960.70% |
US
|
|
| - | - |
US
|
|
| 6.4701 | 493.64% |
AU
|
